Immuron Financial Statements From 2010 to 2024

IMRN Stock  USD 1.89  0.02  1.05%   
Immuron financial statements provide useful quarterly and yearly information to potential Immuron Ltd ADR investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Immuron financial statements helps investors assess Immuron's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Immuron's valuation are summarized below:
Gross Profit
1.7 M
Profit Margin
(1.41)
Market Capitalization
11.4 M
Enterprise Value Revenue
1.2385
Revenue
4.9 M
We have found one hundred twenty available fundamental trends for Immuron Ltd ADR, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Immuron's regular fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 29th of November 2024, Market Cap is likely to drop to about 16.5 M. In addition to that, Enterprise Value is likely to drop to about 7.1 M

Immuron Total Revenue

5.15 Million

Check Immuron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.7 K, Interest Expense of 7.2 K or Total Revenue of 5.1 M, as well as many indicators such as Price To Sales Ratio of 3.66, Dividend Yield of 0.0 or PTB Ratio of 1.41. Immuron financial statements analysis is a perfect complement when working with Immuron Valuation or Volatility modules.
  
Check out the analysis of Immuron Correlation against competitors.

Immuron Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding239.6 M228.2 M98.5 M
Slightly volatile
Total Assets9.3 M15.5 M11.1 M
Slightly volatile
Other Current Liabilities2.1 MM638.4 K
Slightly volatile
Total Current Liabilities2.8 M2.7 M1.5 M
Slightly volatile
Total Stockholder Equity7.9 M12.7 M9.5 M
Slightly volatile
Property Plant And Equipment Net146.6 K154.3 K193 K
Slightly volatile
Accounts Payable744.3 K648.9 K722.2 K
Pretty Stable
Cash12.2 M11.7 MM
Slightly volatile
Non Current Assets Total940.4 K823.6 K1.1 M
Pretty Stable
Cash And Short Term Investments6.2 M11.7 MM
Slightly volatile
Net Receivables846.1 K1.4 M942.3 K
Very volatile
Liabilities And Stockholders Equity10.4 M15.5 M11.1 M
Slightly volatile
Inventory802.1 K1.6 M804.6 K
Pretty Stable
Other Current Assets92 K96.8 K370.9 K
Very volatile
Total Liabilities1.4 M2.8 M1.6 M
Pretty Stable
Total Current AssetsM14.7 M10 M
Slightly volatile
Common Stock46.1 M88.5 M55.6 M
Slightly volatile
Accumulated Other Comprehensive Income1.8 M3.2 MM
Slightly volatile
Net Tangible Assets12.8 M22.6 M11.4 M
Slightly volatile
Property Plant Equipment241.7 K230.2 K79.2 K
Slightly volatile
Net Invested Capital15.3 M22.6 M11.8 M
Slightly volatile
Net Working Capital13.7 M20.9 M10.7 M
Slightly volatile
Capital Stock85.4 M101.7 M70.6 M
Slightly volatile

Immuron Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization43.7 K46 K120.9 K
Slightly volatile
Interest Expense7.2 K7.6 K148.7 K
Slightly volatile
Total Revenue5.1 M4.9 M1.7 M
Slightly volatile
Other Operating Expenses11.2 M10.7 M5.6 M
Slightly volatile
Research Development5.6 M5.4 M2.3 M
Slightly volatile
Cost Of Revenue917.4 K1.6 M610.8 K
Slightly volatile
Selling General AdministrativeM4.5 M3.2 M
Slightly volatile
Selling And Marketing Expenses2.1 MM713.3 K
Slightly volatile
Reconciled Depreciation30.5 K56 K20.7 K
Slightly volatile

Immuron Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow18 M17.2 M7.7 M
Slightly volatile
Capital Expenditures185195134.4 K
Slightly volatile
End Period Cash Flow12.2 M11.7 MM
Slightly volatile
Sale Purchase Of Stock2.5 M2.6 M922.3 T
Pretty Stable
Depreciation70.9 K43.8 K203.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.663.857432.6887
Very volatile
PTB Ratio1.411.48813.7408
Slightly volatile
Days Sales Outstanding128103187
Very volatile
Book Value Per Share0.0530.05580.2553
Slightly volatile
Average Payables144.5 K152.1 K517.2 K
Slightly volatile
Capex To Depreciation0.0040.00423.1001
Slightly volatile
PB Ratio1.411.48813.7408
Slightly volatile
Inventory Turnover0.940.98830.8599
Slightly volatile
Days Of Inventory On Hand457369802
Very volatile
Payables Turnover2.352.41361.3236
Pretty Stable
Sales General And Administrative To Revenue0.880.92224.6627
Pretty Stable
Average Inventory717.2 K771.7 K846.3 K
Pretty Stable
Research And Ddevelopement To Revenue1.791.09642.3993
Very volatile
Capex To Revenue0.00.00.2755
Slightly volatile
Cash Per Share0.04860.05120.1829
Slightly volatile
Days Payables Outstanding144151626
Pretty Stable
Income Quality1.010.80150.89
Pretty Stable
Intangibles To Total Assets0.180.240.2542
Very volatile
Net Debt To EBITDA0.951.85451.7116
Slightly volatile
Current Ratio5.495.45638.1387
Pretty Stable
Receivables Turnover5.193.53344.2707
Very volatile
Graham Number0.190.19550.6597
Slightly volatile
Shareholders Equity Per Share0.0530.05580.2543
Slightly volatile
Debt To Equity0.04760.05010.6551
Slightly volatile
Capex Per Share0.00.00.0476
Slightly volatile
Average Receivables852.9 K812.2 K472.9 K
Slightly volatile
Revenue Per Share0.02040.02150.0259
Slightly volatile
Interest Debt Per Share0.00.00.0185
Slightly volatile
Debt To Assets0.03770.03970.1097
Slightly volatile
Operating Cycle585473990
Very volatile
Price Book Value Ratio1.411.48813.7408
Slightly volatile
Days Of Payables Outstanding144151626
Pretty Stable
Ebt Per Ebit0.691.19580.8657
Very volatile
Company Equity Multiplier1.451.22352.3299
Slightly volatile
Long Term Debt To Capitalization0.440.80.7622
Slightly volatile
Total Debt To Capitalization0.04510.04740.1602
Slightly volatile
Debt Equity Ratio0.04760.05010.6551
Slightly volatile
Quick Ratio4.954.86917.509
Pretty Stable
Net Income Per E B T0.730.880.9069
Slightly volatile
Cash Ratio3.234.31925.6658
Slightly volatile
Days Of Inventory Outstanding457369802
Very volatile
Days Of Sales Outstanding128103187
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.181.01.0918
Slightly volatile
Price To Book Ratio1.411.48813.7408
Slightly volatile
Fixed Asset Turnover22.031.765240.5676
Very volatile
Debt Ratio0.03770.03970.1097
Slightly volatile
Price Sales Ratio3.663.857432.6887
Very volatile
Asset Turnover0.340.31530.1653
Slightly volatile
Price Fair Value1.411.48813.7408
Slightly volatile

Immuron Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap16.5 M18.9 M20.4 M
Slightly volatile

Immuron Fundamental Market Drivers

Cash And Short Term Investments11.7 M

Immuron Upcoming Events

30th of August 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

About Immuron Financial Statements

Immuron investors utilize fundamental indicators, such as revenue or net income, to predict how Immuron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.5 M
Total Revenue4.9 M5.1 M
Cost Of Revenue1.6 M917.4 K
Sales General And Administrative To Revenue 0.92  0.88 
Research And Ddevelopement To Revenue 1.10  1.79 
Revenue Per Share 0.02  0.02 
Ebit Per Revenue(1.18)(1.24)

Pair Trading with Immuron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immuron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuron will appreciate offsetting losses from the drop in the long position's value.

Moving together with Immuron Stock

  0.72ELAN Elanco Animal HealthPairCorr

Moving against Immuron Stock

  0.84EWTX Edgewise TherapeuticsPairCorr
  0.83ESPR Esperion Therapeutics Buyout TrendPairCorr
  0.82GILD Gilead SciencesPairCorr
  0.79BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.67GANX Gain TherapeuticsPairCorr
The ability to find closely correlated positions to Immuron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immuron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immuron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immuron Ltd ADR to buy it.
The correlation of Immuron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immuron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immuron Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immuron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Immuron Ltd ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Immuron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Immuron Ltd Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Immuron Ltd Adr Stock:
Check out the analysis of Immuron Correlation against competitors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.79)
Revenue Per Share
0.88
Quarterly Revenue Growth
1.086
Return On Assets
(0.17)
Return On Equity
(0.43)
The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.